• 同一論文・投稿 (to be publishedを含む)ごとのリストのため、新規公開エントリーより以前に公開されたエントリーも含まれている。
  • カラムTitleは、To be publishedの投稿については仮置であり、ジャーナルからの公開時には変更されている可能性がある。
  •  カラムRelease Dateの"AUTH"は"編集処理済、登録者の確認・同意待ち"を意味し、"HPUB"は"論文発表待ち"を意味する。
  • 2020年9月2日以前に公開された構造については、PDBj Web siteの新型コロナウイルスの構造情報 全エントリー, または, crisp_bioの過去記事「新型コロナウイルスのPDB公開構造一覧 - その6その5その4その3その2その1」参照
  • 2020-09-02日以後、PDBの更新に合わせて新規公開分を原則毎週水曜日に投稿

    ID

    Title

    Release Date

    論文

    Fu, L.F.,Gilski, M.,Shabalin, I.,Gao, G.F.,Qi, J.X.

    Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease

    Nat Commun 2020-09-04

    7D1M

    7BRRを置換: Crystal structure of the SARS-CoV-2 main protease complexed with GC376.

    2020-10-28

    7BRO

    Crystal structure of the 2019-nCoV main protease

    2020-05-13

    7BRP

    Crystal structure of the 2019-nCoV main protease complexed with Boceprevir

    2020-05-13

    7C6U 

    Crystal structure of SARS-CoV-2 complexed with GC376

    2020-09-02

    7C6S

    Crystal structure of the SARS-CoV-2 main protease complexed with Boceprevir

    2020-09-02

    投稿

    Brosey, C.A.,Houl, J.H.,Katsonis, P.,Balapiti-Modarage, L.P.F.,Bommagani, S.,Moiani, D.,Bacolla, A.,Arvai, A.,Link, T.,Warden, L.S.,Lichtarge, O.,Jones, D.E.,Ahmed, Z.,Tainer, J.A.

    Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors

    To be published

    7KG3

    Crystal structure of CoV-2 Nsp3 Macrodomain

    2020-10-28

    7KG8

    編集処理完了、指定の時期まで公開待ち

    HOLD

    7KFP

    編集処理完了、指定の時期まで公開待ち

    HOLD

    7KG0

    編集処理完了、指定の時期まで公開待ち

    HOLD

    7KG7

    編集処理完了、指定の時期まで公開待ち

    HOLD

    7KG6

    編集処理完了、指定の時期まで公開待ち

    HOLD

    投稿

    Noske, G.D.,Nakamura, A.M.,Gawriljuk, V.O.,Lima, G.A.M.,Zeri, A.C.M.,Nascimento, A.F.Z.,Oliva, G.,Godoy, A.S.

    SARS-CoV-2 Main protease immature form - apo structure

    To be publsihed

    7KFI

    SARS-CoV-2 Main protease immature form - apo structure

    2020-10-28

    投稿

    Lee, J.,Worrall, L.J.,Vuckovic, M.,Rosell, F.I.,Gentile, F.,Ton, A.T.,Caveney, N.A.,Ban, F.,Cherkasov, A.,Paetzel, M.,Strynadka, N.C.J.

    Crystallographic structure of wild-type SARS-CoV-2 Main Protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site

    To be published

    7KHP

    Acyl-enzyme intermediate structure of SARS-CoV-2 Mpro in complex with its C-terminal autoprocessing sequence.

    2020-10-28

    論文

    Daly, J.L.,Simonetti, B.,Klein, K.,Chen, K.E.,Kavanagh Williamson, M.,Anton-Plagaro, C.,Shoemark, D.K.,Simon-Gracia, L.,Bauer, M.,Hollandi, R.,Greber, U.F.,Horvath, P.,Sessions, R.B.,Helenius, A.,Hiscox, J.A.,Teesalu, T.,Matthews, D.A.,Davidson, A.D.,Collins, B.M.,Cullen, P.J.,Yamauchi, Y.

    Neuropilin-1 is a host factor for SARS-CoV-2 infection

    Science 2020-10-20
    crisp_bio 2020-10-23

    7JJC

    Crystal structure of neuropilin-1 b1 domain in complex with SARS-CoV-2 S1 C-end rule (CendR) peptide

    2020-10-28

    投稿

    Guenther, S.,Reinke, P.,Oberthuer, D.,Yefanov, O.,Gelisio, L.,Ginn, H.,Lieske, J.,Brehm, W.,Rahmani Mashour, A.,Knoska, J.,Pena Esperanza, G.,Koua, F.,Tolstikova, A.,Groessler, M.,Fleckenstein, H.,Trost, F.,Galchenkova, M.,Gevorkov, Y.,Li, C.,Awel, S.,Paulraj, L.X.,Ullah, N.,Falke, S.,Alves Franca, B.,Schwinzer, M.,Brognaro, H.,Werner, N.,Perbandt, M.,Seychell, B.,Meier, S.,Giseler, H.,Melo, D.,Dunkel, I.,Lane, T.J.,Peck, A.,Saouane, S.,Hakanpaeae, J.,Meyer, J.,Noei, H.,Gribbon, P.,Ellinger, B.,Kuzikov, M.,Wolf, M.,Zhang, L.,Ehrt, C.,Pletzer-Zelgert, J.,Wollenhaupt, J.,Feiler, C.,Weiss, M.,Schulz, E.C.,Mehrabi, P.,Norton-Baker, B.,Schmidt, C.,Lorenzen, K.,Schubert, R.,Han, H.,Chari, A.,Fernandez Garcia, Y.,Hilgenfeld, R.,Rarey, M.,Zaliani, A.,Chapman, H.N.,Pearson, A.,Betzel, C.,Meents, A.

    Structure of SARS-CoV-2 Main Protease bound to Calpeptin

    To be published

    7AKU

    Structure of SARS-CoV-2 Main Protease bound to Calpeptin.

    2020-10-28

    投稿

    Noske, G.D.,Nakamura, A.M.,Gawriljuk, V.O.,Lima, G.A.M.,Zeri, A.C.M.,Nascimento, A.F.Z.,Oliva, G.,Godoy, A.S.

    SARS-CoV-2 Main protease immature form - fragment BBV-136614527

    To be published

    7KFJ

    SARS-CoV-2 Main protease immature form - fragment BBV-136614527

    2020-10-28

    投稿

    Rujas, E.,Kucharska, I.,Tan, Y.Z.,Benlekbir, S.,Cui, H.,Zhao, T.,Wasney, G.,Budylowski, P.,an, S.,Glanville, J.,Christie-Holmes, N.,Mubareka, S.,Gray-OweGuvenc, F.,Newton, J.C.,Sicard, T.,Semesi, A.,Muthuraman, K.,Nouanesengsy, A.,Prieto, K.,Bueler, S.A.,Youssef, S.,Liao-Chn, S.D.,Rubinstein, J.L.,Treanor, B.,Julien, J.P.

    Multivalency transforms SARS-CoV-2 antibodies into broad and ultrapotent neutralizers

    bioRxiv 2020-10-16

    7K9Z

    Crystal structure of SARS-CoV-2 receptor binding domain in complex with the Fab fragments of neutralizing antibodies 298 and 52

    2020-10-28

    投稿

    Veverka, V.

    The SARS-CoV-2 nucleocapsid phosphoprotein N-terminal domain in complex with 10mer ssRNA

    To be published

    7ACT

    The SARS-CoV-2 nucleocapsid phosphoprotein N-terminal domain in complex with 10mer ssRNA

    2020-10-28